WBBA commends Bristol-Myers Squibb's decision to stay in Seattle
...and we are not alone!
Statement from Mayor Mike McGinn
“I welcome the news that Bristol-Myers Squibb is keeping ZymoGenetics in Seattle. ZymoGenetics was founded in Seattle 20 years ago, and it has been an early and consistent leader in the region’s biotechnology industry. Bristol-Myers Squibb’s decision to keep the company and its 280 employees here after purchasing it last year reaffirms Seattle and Washington State as leaders in life sciences research and development. We have premier research institutions and a healthy ecosystem of national and international companies. I thank Governor Gregoire, Congressman Inslee and the Washington Biotechnology & Biomedical Association for their partnership with the city in working with this innovative company.”
Statement from Congressman Jay Inslee
“Bristol-Myers Squibb has made a wise decision in keeping research operations here in the Puget Sound,” said Rep. Jay Inslee. “Life science continues to be a key economic driver for Washington State. I was proud to stand with Governor Gregoire, Mayor McGinn, and the Washington Biotechnology & Biomedical Association to make the case for the Puget Sound, home to the most talented workforce in the country.”
...and it's making news!
Bristol-Myers Squibb to Stay in Seattle, Keep ZymoGenetics Workers | Xconomy | Luke Timmerman | January 25, 2011
ZymoGenetics parent Bristol-Myers to keep a Seattle presence | The Seattle Times | Sanjay Bhatt | January 25, 2011
Zymo to stay in Seattle | Puget Sound Business Journal | Clay Holtzman | January 25, 2011
The Seattle Office of Economic Development posts in their Daily Digest